- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Adenocarcinoma in Finland
Total 510 results
-
University of OuluOulu University HospitalTerminatedUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic NeoplasmsFinland
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Blue Earth DiagnosticsParexelCompletedProstate CancerUnited States, Finland, Germany, Netherlands
-
University of OuluOulu University HospitalCompletedProstatic NeoplasmsFinland
-
Bristol-Myers SquibbCompleted
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
Steba Biotech S.A.ICON plc; International Drug Development InstituteCompletedCancer of the ProstateNetherlands, Spain, France, Germany, United Kingdom, Finland, Italy, Sweden
-
DendreonPRA Health SciencesActive, not recruitingAdenocarcinoma of the ProstateUnited States
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Steba Biotech S.A.CompletedProstate CancerSpain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Ferring PharmaceuticalsCompletedProstate CancerDenmark, Sweden, Finland, Hungary, Norway, Romania, Russian Federation
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Incyte CorporationTerminatedProstate CancerUnited States
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
Antisoma ResearchCompletedProstate CancerUnited States
-
AgennixTerminatedProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Advaxis, Inc.Merck Sharp & Dohme LLCCompleted
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
GP-PharmCompletedProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate AdenocarcinomaUnited States, Canada, Hong Kong, Switzerland, India, Ireland
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
-
Tampere University HospitalTampere University; University of Eastern Finland; Finnish Cultural Foundation; Fimlab laboratoriesCompleted
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
Blue Earth DiagnosticsParexelCompletedProstate CancerUnited States, Finland, Netherlands
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Ferring PharmaceuticalsTerminatedProstate CancerUnited States, Netherlands, United Kingdom, Hungary, Belgium, Czech Republic, Finland, Germany, Mexico, Poland, Romania, Ukraine, Canada
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
SanofiCompletedProstate CancerAustralia, Portugal, Spain, Peru, Sweden, Romania, Russian Federation, Belarus, Israel, France, Italy, Denmark, Turkey, Germany, United States, Brazil, Canada, China, Czechia, Finland, Japan, Mexico, Poland, Taiwan, Ukraine
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom, Netherlands, Ireland, Greece, France, Belgium, Denmark, Norway, Italy, Slovakia, Switzerland, Portugal, Finland, Hungary, Germany
-
Active Biotech ABCompleted
-
Tampere University HospitalCompletedProstatic Neoplasms | Urinary Incontinence | Erectile DysfunctionFinland
-
BayerRecruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Czechia, France, Hungary, Italy, Poland, Spain, Taiwan, United Kingdom, Korea, Republic of, Singapore, Hong Kong, Australia, Finland, Germany, Israel, Lithuania, Russian Federation, Turkey, Austria
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States